ClinicalTrials

Breathing New Life? Exploring Hyperbaric Oxygen Therapy's Role in Tackling Long COVID

New Hepatitis C Treatment Centers: Cutting‑Edge Care Now Within Reach

A Glimmer of Hope: New Experimental Drugs Hint at a Functional Cure for Chronic Hepatitis B

RSV Vaccine Hope Dims Amidst Bombshell Lawsuit Over Testing Ethics

A New Dawn in Medicine: Kailera's Triple-G Drug Unveils Staggering Potential

Imagine This: One Shot, Drastically Lower Cholesterol. A Game-Changer on the Horizon?

Oxford‑Serum’s Race to Deliver a New Ebola Vaccine

Ensitrelvir: The Long‑Awaited Oral Antiviral that Could Guard Us Against Future Viral Threats

Ebola’s Latest Outbreak: Emergency Declared Yet No Vaccine Available

A Crucial Step Forward: Oxford Pioneers Vaccine Trials for Bundibugyo Ebola

Peptide Research: What You Really Need to Know

Aardvark Therapeutics Shares Crater: FDA Halts Promising Prader-Willi Syndrome Drug

A New Era for Hearing: Gene Therapy Approved for Inherited Deafness

Ivermectin's Unfulfilled Promise: A Potential Cancer Drug Quashed

The Quiet Conversation: Unpacking Medications and Your Brain's Future

A Renewed Sense of Hope: Roche's Ocrevus Continues to Impress in MS Care

A New Frontier in Cancer Treatment: The Promise of mRNA Vaccines

The Quest for Hair: Nektar's Rezpeg Promises a New Dawn for Alopecia Sufferers

Cannabis's Untapped Potential: Why Medical Research Is Lagging Behind the Green Rush

A Luminary's Farewell: Remembering Dr. Iris Long

A Game Changer? Allogene's 'Off-the-Shelf' CAR T Therapy Shows Stunning Promise in B-Cell Lymphoma

The Unraveling of Kezar Life Sciences: How an FDA Delay Triggered a Biotech Startup's Collapse

Jasper Therapeutics Forges Ahead: A Deep Dive into 2025 Results and Future Horizons for Briquilimab

A New Chapter Unfolds: Cue Biopharma Announces Leadership Transition Amidst Clinical Advancements

Inspira Technologies' Transformative 2025: Unpacking a Year of Strategic Growth and Innovation

Quoin Pharmaceuticals Unveils Significant Clinical Progress and Strong Financial Standing for 2025

Unpacking Newron's Q4 2023: A Closer Look at Evenamide's Journey and Financial Health

A Deeper Look at Assembly Biosciences' Latest Financial Journey

Assembly Biosciences Navigates 2025: A Deep Dive into Financial Strategy and Groundbreaking Clinical Advances

Pelthos Therapeutics Unveils 2025 Financials, Charting Course for Future Innovations

Zentalis Pharmaceuticals to Unveil Promising Cancer Therapy Updates at AACR 2026

A Glimmer of Hope: Beyond Cancer's Early Clinical Results Spark Optimism

uniQure Soars: Mizuho Upgrade Rekindles Hope for Huntington's Gene Therapy

Engene Holdings: Why 2026 Could Be Their Pivotal Moment

ImmunityBio's Stock Plunge: Can Dr. Soon-Shiong's Cancer Science Convince Skeptical Investors?

A New Dawn in Pain Relief: Vertex Pharmaceuticals' Breakthrough Soars Stock

A Stinging Setback: Incyte's Cancer Therapy Fails to Clear FDA's High Bar

A Nuanced Look at Helus Pharma's HLP004 for Anxiety: Beyond the Primary Endpoint

Teva Secures Landmark $400 Million Investment from Blackstone for Pivotal Respiratory Drug